Hepatitis Updates: Lamivudine Durability in HBV Treatment; Racial Differences Regarding HCV, Iron Stores &Response to HCV Therapy; Threshold for Neutropenia in Interferon Therapy; ALT in Predicting Liver Fibrosis; RNA Interference in Discovering Drugs for HBV.

Conference Reports for NATAP


Hepatitis Updates: Lamivudine Durability in HBV Treatment; Racial Differences Regarding HCV, Iron Stores &Response to HCV Therapy; Threshold for Neutropenia in Interferon Therapy; ALT in Predicting Liver Fibrosis; RNA Interference in Discovering Drugs for HBV.

	Hepatitis C in India - (4/9/03) Threshold for neutropenia in the adjustment of interferon treatment in HCV infection - (4/9/03) Prediction of histology in hepatitis C - (4/9/03) Inhibition of hepatitis B virus expression and replication by RNA interference - (4/9/03) Racial differences in the relationship between hepatitis C infection and iron stores - (4/9/03) Durability of serologic response after lamivudine treatment of chronic hepatitis B: 3 year follow-up - (4/9/03)